Medical Devices Research Reports Sterile Lancets Market

Sterile Lancets Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 - 2026
Sterile Lancets Market, by Product Type (Conventional Sterile Lancets and Safety Sterile
Lancet), by Application (Diabetes and Others), by Distribution Channel (Retail
Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Geography - Size,
Share, Outlook, and Opportunity Analysis, 2018 - 2026
Sterile lancets are single-use disposable needles that are used for blood sampling by puncturing the
skin. Sterile lancets can be used independently as safety lancet or they can be used along with the
lancing device, which holds the lancet while pricking the skin. Skin testing for allergies can also be
performed with the help of sterile lancets. Sterile lancets are most commonly used in diabetic patients
for checking blood glucose level, however they are also used for collecting blood samples to perform
other diagnostic tests. It offers safety against accidental injuries and contamination.
Sterile Lancets Market – Dynamics
Increasing prevalence of diabetes is one of the major factors driving growth of the sterile lancet market.
For instance, according to the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around
425 million patients were suffering from diabetes worldwide by end of 2017 and it is expected to reach
around 629 million by 2045. Moreover, over 40% people suffering from diabetes are still undiagnosed,
especially in regions such as Asia Pacific, Middle East and some part of North Africa. These patients
would require insulin therapy, which would increase the demand for sterile lancets and fuel growth of
the sterile lancets market.
Request Sample Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/1994
According to the World Health Organization (WHO) 2012 factsheet, diabetes is one of the top three
causes of death from non-communicable diseases. Changes in lifestyle with more sedentary routine
and high calorie consumption leads to obesity. Increasing geriatric population is another factor driving
the sterile lancet market growth, as older people often require continuous glucose monitoring due to
large incidences of uncontrolled diabetes. As per 2017 IDF estimation, there were around 98 million
diabetic people worldwide above the age of 65 years in 2017, which is expected to increase to around
191 million by 2045.
Globally stringent demands for safe injection practices to collect blood is expected to propel demand
for sterile lancets, as it avoids the chances of contamination caused due to blood borne pathogens. For